13F-HR filed by Sio Capital Management, LLC
Sio Capital Management, LLC filed this 13F-HR for the quarter ended 2018-03-31, filed 2018-05-15, with 31 holding rows worth $166,415,000.
- Accession
- 0001214659-18-003771
- Filer
- CIK 1482416
- Filed
- 2018-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2018
A holdings report, 31 entries on the cover page, a total value of $166,415,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $166,415,000 with VALUE read as thousands by filing date, 13F file number 028-13691. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CATALYST BIOSCIENCES INC | 14888D208 | COM | 1,149,989 | $29,670,000 | thousands by filing date | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 408,621 | $16,378,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 657,411 | $12,326,000 | thousands by filing date | |
| Elevance Health, Inc. | 036752103 | COM | 52,387 | $11,509,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 31,900 | $8,735,000 | thousands by filing date | |
| UnitedHealth Group Inc | 91324P102 | COM | 30,400 | $6,506,000 | thousands by filing date | |
| Eli Lilly and Company | 532457108 | COM | 82,363 | $6,372,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 114,856 | $6,256,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 225,463 | $6,160,000 | thousands by filing date | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 1,276,845 | $5,580,000 | thousands by filing date | |
| WELLCARE HEALTH PLANS INC | 94946T106 | COM | 28,653 | $5,548,000 | thousands by filing date | |
| AETNA INC NEW | 00817Y108 | COM | 31,635 | $5,346,000 | thousands by filing date | |
| HCA Healthcare Inc | 40412C101 | COM | 52,330 | $5,076,000 | thousands by filing date | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 36,200 | $4,277,000 | thousands by filing date | |
| ACCENDRA HEALTH INC | 690732102 | COM | 273,640 | $4,255,000 | thousands by filing date | |
| TRUBRIDGE INC | 205306103 | COM | 113,860 | $3,325,000 | thousands by filing date | |
| CONFORMIS INC | 20717E101 | COM | 2,200,681 | $3,191,000 | thousands by filing date | |
| OMNICELL COM COM | 68213N109 | Stock | 70,226 | $3,048,000 | thousands by filing date | |
| KONINKLIJKE PHILIPS N V NY REGIS SHS NEW | 500472303 | ADR | 76,742 | $2,940,000 | thousands by filing date | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 274,800 | $2,891,000 | thousands by filing date | put |
| MYLAN NV | N59465109 | SHS EURO | 69,000 | $2,841,000 | thousands by filing date | |
| CELGENE CORP | 151020104 | COM | 31,180 | $2,782,000 | thousands by filing date | |
| Johnson & Johnson | 478160104 | COM | 20,000 | $2,563,000 | thousands by filing date | put |
| MEI PHARMA INC | 55279B202 | COM NEW | 934,563 | $1,935,000 | thousands by filing date | |
| HILL ROM HLDGS INC | 431475102 | COM | 21,449 | $1,866,000 | thousands by filing date | |
| DERMIRA INC | 24983L104 | COM | 190,300 | $1,520,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 72,826 | $1,293,000 | thousands by filing date | |
| HERON THERAPEUTICS INC | 427746102 | COM | 29,500 | $814,000 | thousands by filing date | put |
| CURIS INC | 231269101 | COM | 834,551 | $545,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 193,290 | $474,000 | thousands by filing date | |
| ACTINIUM PHARMACEUTICALS INC | 00507W107 | COM | 1,076,200 | $393,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-18-003771 | this filing | 2018-05-15 | acceptance time not in the bulk data set |